Neurodegenerative focus Pentara specializes in statistical consulting for neurodegenerative diseases, presenting a targeted opportunity to upsell advanced study design, data management, and statistical analysis services to biotech and pharma clients focused on CNS disorders.

Clinical trial leadership With end-to-end support from study initiation to results presentation, Pentara offers a compelling value proposition for sponsors seeking to streamline statistical workflows, reduce time to insight, and ensure regulatory-ready analyses.

AI and analytics Recent collaboration involving AI-driven anomaly detection signals potential for expanded AI/ML offerings, including automated data quality monitoring, risk-based monitoring, and adaptive design analytics.

Growing revenue Revenue in the mid-range millions and a mid-sized team position Pentara as a scalable partner for mid-to-large biotech programs, with room to grow services such as data management outsourcing, programming, and regulatory support.

Strategic partnerships Recent joint initiative with NetraMark to co-brand and launch an intelligence tool highlights openness to collaborations and reseller or co-development opportunities to broaden market reach and add new analytic offerings.